Drug General Information
Drug ID	D0G2CY
Former ID	DNC009204
Drug Name	(+/-)-3-allylazetidin-2-one
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[529529]
Structure		Download 2D MOL 3D MOL
Formula	C6H9NO
Canonical SMILES	C=CCC1CNC1=O
InChI	1S/C6H9NO/c1-2-3-5-4-7-6(5)8/h2,5H,1,3-4H2,(H,7,8)
InChIKey	XWLCLNCCEDQVSS-UHFFFAOYSA-N
PubChem Compound ID	20449950
Target and Pathway
Target(s)	Fatty-acid amide hydrolase	Target Info	Inhibitor	[529529]
BioCyc Pathway	Anandamide degradation
KEGG Pathway	Retrograde endocannabinoid signaling
PANTHER Pathway	Anandamide degradation
References
Ref 529529	Bioorg Med Chem Lett. 2008 Jul 15;18(14):4163-7. Epub 2008 May 24.3-Alkenyl-2-azetidinones as fatty acid amide hydrolase inhibitors.
Ref 529529	Bioorg Med Chem Lett. 2008 Jul 15;18(14):4163-7. Epub 2008 May 24.3-Alkenyl-2-azetidinones as fatty acid amide hydrolase inhibitors.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.